Literature DB >> 16448971

A population-based case-control study on the effect of bronchial asthma during pregnancy for congenital abnormalities of the offspring.

Lilla Tamási1, Akos Somoskövi, Veronika Müller, Zoltán Bártfai, Nándor Acs, Erzsébet Puhó, Andrew E Czeizel.   

Abstract

Bronchial asthma is one of the most common maternal diseases complicating pregnancy. We assessed the risks of congenital abnormalities in a case-control population-based analysis using the dataset of the Hungarian Case-Control Surveillance of Congenital Abnormalities between 1980 and 1996. Of the 22,843 cases with congenital abnormalities, 511 (2.2%) had mothers with bronchial asthma, while of the 38,151 matched control subjects without congenital abnormalities 757 (2.0%) had mothers with bronchial asthma (unadjusted prevalence odds ratios [POR] 1.2; 95% CI: 1.0-1.3). In all mothers with bronchial asthma, a higher incidence of respiratory tract infections and higher drug intake could be observed. In the case group of medically recorded bronchial asthma, a slightly increased risk for club foot has been revealed. However, this weak association could be explained by the higher proportion of preterm births in this group. The main limitation of the analysis was that at the time of data collection only a small proportion of pregnant mothers were using anti-asthma medications recommended by the actual guidelines.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16448971     DOI: 10.1080/02770900500448803

Source DB:  PubMed          Journal:  J Asthma        ISSN: 0277-0903            Impact factor:   2.515


  8 in total

1.  Maternal bronchodilator use and the risk of orofacial clefts.

Authors:  JeanPierre W Munsie; Shao Lin; Marilyn L Browne; Kimberly A Campbell; Alissa R Caton; Erin M Bell; Sonja A Rasmussen; Paul A Romitti; Charlotte M Druschel
Journal:  Hum Reprod       Date:  2011-09-15       Impact factor: 6.918

2.  Safety of using montelukast during pregnancy.

Authors:  Gideon Koren; Moumita Sarkar; Adrienne Einarson
Journal:  Can Fam Physician       Date:  2010-09       Impact factor: 3.275

3.  Maternal asthma medication use and the risk of selected birth defects.

Authors:  Shao Lin; Jean Pierre W Munsie; Michele L Herdt-Losavio; Charlotte M Druschel; Kimberly Campbell; Marilyn L Browne; Paul A Romitti; Richard S Olney; Erin M Bell
Journal:  Pediatrics       Date:  2012-01-16       Impact factor: 7.124

4.  Montelukast use during pregnancy: a multicentre, prospective, comparative study of infant outcomes.

Authors:  Moumita Sarkar; Gideon Koren; Sanjog Kalra; Angela Ying; Carlo Smorlesi; Marco De Santis; Orna Diav-Citrin; Meytal Avgil; Sharon Voyer Lavigne; Matti Berkovich; Adrienne Einarson
Journal:  Eur J Clin Pharmacol       Date:  2009-12       Impact factor: 2.953

Review 5.  Safety of inhaled budesonide: clinical manifestations of systemic corticosteroid-related adverse effects.

Authors:  Camilla Christensson; Anders Thorén; Bengt Lindberg
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

6.  Asthma Medication Use and Risk of Birth Defects: National Birth Defects Prevention Study, 1997-2011.

Authors:  Meredith M Howley; Eleni A Papadopoulos; Carla M Van Bennekom; Alissa R Van Zutphen; Suzan L Carmichael; JeanPierre W Munsie; Michele L Herdt; Marilyn L Browne
Journal:  J Allergy Clin Immunol Pract       Date:  2020-07-31

7.  Asthma in pregnancy - from immunology to clinical management.

Authors:  Lilla Tamási; Anikó Bohács; Ildikó Horváth; György Losonczy
Journal:  Multidiscip Respir Med       Date:  2010-08-31

8.  Circulating survivin levels in healthy and asthmatic pregnancy.

Authors:  Andras Bikov; Renata Bocskei; Noemi Eszes; Aniko Bohacs; Gyorgy Losonczy; Janos Rigo; Ildiko Horvath; Lilla Tamasi
Journal:  Reprod Biol Endocrinol       Date:  2014-09-23       Impact factor: 5.211

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.